Pharmacologic management of the chronically aggressive psychiatric patient

Psychiatric Annals

Volumn 28, Issue 7, 1998, Pages 367-370

  Hughes, Douglas H ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032360643     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19980701-06     Document Type: Article

References (32)

1. Asnis GM, Kaplan ML, Hundorfean G, Saeed W. Violence and homicidal behaviors in psychiatric disorders. Psychiatr Clin North Am. 1997;20:405-425.
2. Bernhardt PC. Influences of serotonin and testosterone in aggression and dominance: convergence with social psychology. Curr Directions Psychol Sci. 1997;6:44-48.
3. Kavoussi R, Armstead P, Coccaro E. The neurobiology of impulsive aggression. Psychiatr Clin North Am. 1997;20:395-403.
4. Coccaro EF, Silverman JM, Klar HM, Horvath TB. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry. 1994;51:318-324.
5. Hughes DH. Suicide and violence assessment in psychiatry. Gen Hosp Psychiatry. 1996;18:416-421.
6. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997;20:427-451.
7. Volavka J. Pharmacological treatment of violence. In: Volavka J, ed. Neurobiology of Violence. Washington, DC: American Psychiatric Press; 1995:267-290.
8. Conacher GN. Pharmacological approaches to impulsive and aggressive behavior. In: Webster CD, Jackson MA, eds. Impulsivity. New York, NY: The Guilford Press; 1997:394-408.
9. Sheard MH. Effects of lithium on human aggression. Nature. 1971;203:113-114.
10. Sheard MH, Martin JL, Bridges CI, et al. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry. 1976;133:1409-1413.
11. Luchins DJ. Carbamazepine in violent non-epileptic schizophrenics. Psychopharmacol Bull. 1984;20:569-571.
12. Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry. 1998;155:54-61.
13. Barratt ES. The use of anticolvulsant in aggression and violence. Psychopharmcol Bull. 1993;29:75-81.
14. Fava M, Rosenbaum JF, McCarthy MK. Anger attacks in depressed outpatients and their response to fluoxetine treatment. Am J Psychiatry. 1993;150:1158-1163.
15. Davis JM, Leach A, Merk B, Janicak P. Treatment of steroid psychoses. Psychiatric Annals. 1992;22:487-491.
16. Miczek KA. The psychopharmacology of aggression. In Iversen LL, Iverson SD, Snyder SH, eds. Handbook of Psychopharmocology. New York: Plenium Publishers; 1987:230-231.
17. Ratey J, Leveroni C, Kilmer D. The effects of clozapine on severely aggressive psychiatric inpatients on a difficult to manage unit of a state hospital. J Clin Psychiatry. 1993;54:1-6.
18. Su T, Tuskan J, Tsao L. Aggression during drug-free and antipsychotic treatment I inpatients with chronic schizophrenia, using the overt aggression scale. Presented at the American College of Neuropsychopharmacology Meeting, San Juan, Puerto Rico, 1994.
19. Czobor P, Volavka J, Meibach RC. Effects of resperidone on hostility in schizophrenia. Journal of Clinical Psychopharmacology. 1995;15:243-249.
20. Bick PA, Hannah AL. Intramuscular lorazepam to restrain violent patients (Letter). Lancet. 1986;1:206.
21. Brooke NM, Patterson DR, Questad KA. The treatment of agitation during initial hospitalization after traumatic brain injury. Arch Phys Med Rehabil. 1992;73:917-921.
22. Greendyke RM, Kanter DR, Schuster DB. Propranolol treatment of assaultive patients with organic brain disease. J Nerv Ment Dis. 1986;174:290-294.
23. Ratey J, Mikkelsen E, Smith G. Beta blockers in their severely and profoundly mentally retarded. J Clin Psychopharmacol. 1986;6:103-107.
24. Artigas F. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Arch Gen Psychiatry. 1995;52:969-971.
25. Cramer JA. Partial medication compliance: the enigma in poor medical outcomes. American Journal of Managed Care. 1995;1:45-52.
26. Siegal FP. Lithium for steroid-induced psychosis. N Engl J Med. 1978;299:155-156.
27. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196-201.
28. Hughes DH. Risk assessment-violence. In: Sederer LI, Rothchild AJ, eds. Acute Care Psychiatry. Baltimore, MD: Williams & Wilkins; 1997:29-46.
29. Coryell W, Miller DD. Perry P. Haloperidol plasma levels and dose optimization. Am J Psychiatry. 1998;1:48-52.
30. Snowden M, Roy-Byrne P. Mental illness and nursing home reform: OBRA-87 ten years later. Psychiatr Serv. 1998;49:229-233.
31. Janelli L, Kanski G, Neary M. Physical restraints: has OBRA made a difference? J Gerontol Nurs. 1994;20: 17-21.
32. Roeder L. Alabama violates consent order in Wyatt lawsuit, court rules. Mental Health Rep. 1997;21:206-207.